|6.90||+0.19 / +2.83%|
Data as of 3:59pm ET
|6.97||+0.0713 / +1.03%|
The 4 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 8.50, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +23.19% increase from the last price of 6.90.
The current consensus among 4 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.